Cargando…
Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion
Among the various types of breast cancer, the luminal B subtype is the most common in young women, and ESR1-CCDC170 (E:C) fusion is the most frequent oncogenic fusion driver of the luminal B subtype. Nevertheless, treatments targeting E:C fusion has not been well established yet. Hence, the aim of t...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913953/ https://www.ncbi.nlm.nih.gov/pubmed/33557149 http://dx.doi.org/10.3390/jcm10040582 |